Automated Molecular PCR Platform

NHS Blood and Transplant · Awarded

Buyer
NHS Blood and Transplant
Status
Awarded
Country
United Kingdom
Region
EU - Western Europe
Sector
Manufacturing
Reference
UK-CFA-ocds-b5fd17-91ed65f2-31ef-427c-9cef-e4e24473a4e8
Published
2026-02-18
Deadline
2025-11-03

Tender summary

In May 2023, universal, post-donation screening for HHV-8 antibodies was added to the portfolio of tests required for deceased organ donor characterisation in the UK. Routine pre-donation testing for other required infection markers continue to be performed on an urgent 24/7 basis by a network of UK wide NHS diagnostic laboratories. MSL Virology require a fully automated platform to perform testing for HHV8 DNA in plasma and whole blood samples. MSL Virology also requires a fully automated platform to perform testing for CMV DNA, HEV RNA and HBV DNA in EDTA plasma samples.

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap